Scinai Immunotherapeutics (SCNI) Change in Receivables (2018 - 2024)
Scinai Immunotherapeutics' (SCNI) quarterly Change in Receivables came in at -$26000.0 in Q4 2024, down 106.99% year-on-year from $372000.0 in Q1 2024, and down 2500.0% quarter-over-quarter from -$1000.0 in Q3 2024.
Scinai Immunotherapeutics (SCNI) Change in Receivables (2018 - 2024) Analysis & Trends
Scinai Immunotherapeutics has disclosed Change in Receivables across 7 years of filings, most recently posting -$26000.0 for Q4 2024.
- Change in Receivables for Q4 2024 came in at -$26000.0, down 106.99% year-over-year; the trailing twelve-month figure through Dec 2024 was $83000.0 (down 71.38% YoY), and the FY2025 annual result was -$10000.0, down 112.05% from the prior year.
- Change in Receivables came in at -$26000.0 for Q4 2024 at Scinai Immunotherapeutics, down from -$1000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.7 million in Q4 2020 to a low of -$2.2 million in Q2 2021.
- The 5-year median for Change in Receivables is -$19000.0 (2022), against an average of -$9000.0.
- Across the five-year window, Change in Receivables jumped 362.42% in 2021 and tumbled 1342.11% in 2022, its largest moves.
- Scinai Immunotherapeutics' Change in Receivables stood at $1.7 million in 2020, then tumbled by 98.9% to $19000.0 in 2021, then sank by 1342.11% to -$236000.0 in 2022, then jumped by 257.63% to $372000.0 in 2023, then tumbled by 106.99% to -$26000.0 in 2024.
- The last three Change in Receivables figures came in at -$26000.0 (Q4 2024), -$1000.0 (Q3 2024), and -$39000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -26,000.00 |
| Dec 31, 2024 | -26,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Mar 31, 2024 | 149,000.00 |
| Mar 31, 2024 | 149,000.00 |
| Dec 31, 2023 | 372,000.00 |
| Dec 31, 2023 | 372,000.00 |
| Sep 30, 2023 | -90,000.00 |
| Sep 30, 2023 | -90,000.00 |
| Jun 30, 2023 | -132,000.00 |
| Jun 30, 2023 | -132,000.00 |
| Mar 31, 2023 | 140,000.00 |
| Mar 31, 2023 | 140,000.00 |
| Dec 31, 2022 | -236,000.00 |
| Dec 31, 2022 | -236,000.00 |
| Sep 30, 2022 | -19,000.00 |
| Sep 30, 2022 | -19,000.00 |